Duke Memory Disorders Clinic
Durham, North Carolina, 27705, United States
Location status: Recruiting
Location contact
Connie Thacker
CONTACT
NCT Number: NCT06041789
People with Alzheimer's disease are at an increased risk of bone fracture. Some studies have shown that those taking donepezil have a lower rate of bone fractures, but the reasons for this are unknown. The purpose of this study is to measure the effect of donepezil treatment on bone metabolism factors including bone mineral density, bone turnover markers, and bone quality.
Participants in this study will have a bone density test and have blood samples collected at the baseline study visit. Participants will then be randomly assigned to donepezil or matching memantine to be taken daily by mouth for 12 months. Blood samples will be collected at 6 and 12 months. A repeat bone density test will be performed at 12 months. Participants will also complete questionnaires at each study visit.
Interested in participating?
Request Info50 year and older
All sexes
Interventional
Phase 2
Durham, North Carolina, 27705, United States
Location status: Recruiting
Connie Thacker
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 mg tablet
10 mg tablet
Time frame: baseline, 12 months
Time frame: baseline, 6 months, 12 months
measured using commercially available ELISA test on serum
Time frame: baseline, 6 months, 12 months
measured using commercially available ELISA test on serum
Time frame: baseline, 12 months
measure of bone quality, using DXA spine images
Contact information is provided by the study sponsor or research team.
Duke University
Other
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism and Fracture Risk Factors Among Older Adults With Mild to Moderate Alzheimer's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07325578
Bone Diseases, Bone Diseases, Metabolic
San Diego, California, United States
View Trial DetailsNCT06059222
Bone Diseases, Bone Diseases, Metabolic
Aarhus, Denmark
View Trial DetailsNCT07677033
Atrophy, Bone Diseases
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07677072
Bone Diseases, Bone Diseases, Metabolic
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial Details